Argent Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Buy |
104,019
+6,136
| +6% | +$149K | 0.78% | 35 |
|
|
2025
Q1 | $2.48M | Buy |
97,883
+10,923
| +13% | +$277K | 0.83% | 30 |
|
|
2024
Q4 | $2.31M | Sell |
86,960
-12,178
| -12% | -$323K | 0.86% | 29 |
|
|
2024
Q3 | $2.87M | Buy |
99,138
+8,001
| +9% | +$232K | 1.07% | 19 |
|
|
2024
Q2 | $2.55M | Buy |
91,137
+10,584
| +13% | +$296K | 1.01% | 20 |
|
|
2024
Q1 | $2.24M | Buy |
80,553
+13,515
| +20% | +$375K | 0.88% | 26 |
|
|
2023
Q4 | $1.93M | Sell |
67,038
-1,868
| -3% | -$53.8K | 0.85% | 27 |
|
|
2023
Q3 | $2.28M | Buy |
68,906
+5,468
| +9% | +$181K | 1.04% | 20 |
|
|
2023
Q2 | $2.33M | Buy |
63,438
+3,034
| +5% | +$111K | 1.07% | 18 |
|
|
2023
Q1 | $2.46M | Buy |
60,404
+3,572
| +6% | +$146K | 1.18% | 18 |
|
|
2022
Q4 | $2.91M | Buy |
56,832
+6
| +0% | +$307 | 1.51% | 15 |
|
|
2022
Q3 | $2.49M | Buy |
56,826
+1,789
| +3% | +$78.3K | 1.45% | 15 |
|
|
2022
Q2 | $2.89M | Buy |
55,037
+2,401
| +5% | +$126K | 1.62% | 14 |
|
|
2022
Q1 | $2.73M | Sell |
52,636
-7,332
| -12% | -$380K | 1.46% | 15 |
|
|
2021
Q4 | $3.54M | Buy |
59,968
+2,339
| +4% | +$138K | 1.91% | 10 |
|
|
2021
Q3 | $2.48M | Buy |
57,629
+7,956
| +16% | +$342K | 1.42% | 15 |
|
|
2021
Q2 | $1.95M | Buy |
49,673
+3,318
| +7% | +$130K | 1.18% | 16 |
|
|
2021
Q1 | $1.68M | Buy |
46,355
+4,068
| +10% | +$147K | 1.08% | 20 |
|
|
2020
Q4 | $1.56M | Sell |
42,287
-1,688
| -4% | -$62.2K | 0.95% | 24 |
|
|
2020
Q3 | $1.53M | Buy |
43,975
+1,388
| +3% | +$48.3K | 1.05% | 23 |
|
|
2020
Q2 | $1.32M | Buy |
42,587
+2,268
| +6% | +$70.4K | 1.01% | 21 |
|
|
2020
Q1 | $1.25M | Buy |
40,319
+13,395
| +50% | +$415K | 1.25% | 19 |
|
|
2019
Q4 | $1.01M | Buy |
+26,924
| New | +$1.01M | 0.76% | 29 |
|